The National Heart, Lung, and Blood Institute has halted a study involving children with sickle cell anemia at risk of stroke because of the high iron overload from blood transfusions. Institute officials said the move was made because data from the trial showed the new treatment being tested as not likely to be better than standard treatments.

Related Summaries